Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER in Acute Manic/Mixed Bipolar I
NCT00309699Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Apr 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of paliperidone in bipolar I disorder, sponsored by Johnson & Johnson. Started Apr 2006; status: completed.
02
Drugs
paliperidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00309699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309699.